Skip to content

Published through 2026-11-18 16:40 UTC · Automated cloud publishing.

Covered eventArchived event

Essilor Stellest 2.0 Interim Trial Results and AI Lens Updates Announced

1 reports1 reporting sourcesUpdated 6 days ago

Understand the event

AI event digest

On November 12, 2026, EssilorLuxottica released six-month interim results from a randomized, double-masked trial evaluating the efficacy of Essilor Stellest 2.0 lenses in children with myopia. The study reported average treatment effects of 0.51D for myopia progression, indicating strong control capabilities during this initial phase. In addition to these clinical findings, the company announced updates to its lens design processes, specifically incorporating artificial intelligence technologies. These developments mark a significant step forward in the ongoing evaluation of the Stellest 2.0 product line, providing early data on its performance compared to previous iterations or standard corrective lenses. The announcement highlights both the clinical progress and the technological advancements being integrated into EssilorLuxottica's optical solutions. As an interim report, these results offer a preliminary view of the long-term potential of the lenses, while the integration of AI design suggests a broader strategic shift toward more personalized and technologically advanced manufacturing methods within the eyewear industry.

AI-generated from reporting · updated 6 days ago

Reporting timeline

Follow the reporting for different perspectives.

11-12
  1. Optometry Today
    Essilor Stellest 2.0 Interim Trial Shows Strong Myopia Control; AI Lens Design Updates Announced

    EssilorLuxottica released six-month interim results from a randomized, double-masked trial evaluating Essilor Stellest 2.0 lenses in children with myopia. The study found average treatment effects of 0.51D for myopia progression and 0.21mm for axial elongation compared to single vision controls. Charlotte Timbury, director of medical and professional affairs for North Europe, noted that these results are comparable to one year of first-generation lens wear. Patient adaptation was high, with 98% of children fully adapting within one week and no drop-outs reported. The design features increased mean power and asphericity across lenslets plus an extra ring of lenslets, while maintaining a 9mm central zone for easier switching from previous generations. Additionally, Essilor announced a new dynamic AI design system for its Varilux XR series, enhancing customization based on evolving visual behaviors.

Event coverage trend

Current coverage 3·Comparable peak 10(11-12 23:00)·Comparable change over 24 hours -49%

02.557.51011-1223:0011-1315:0011-1406:0011-1422:00

Trends compare continuously observed participants only; coverage may be narrower than the current total. Point, click or use arrow keys to inspect hourly values.